Biotech

All Articles

ArsenalBio elevates $325M, turns far from previous lead property

.Toolbox Biosciences is actually moving on up. The cell therapy provider has added $325 thousand in ...

Lilly- supported fat burning biotech documents IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has actually fil...

Aelis' marijuana use medication fails period 2b, driving Indivior to reassess $100M choice

.Aelis Farma's chances of protecting an easy, favorable selection on a $one hundred thousand option ...

ProKidney standstills period 3 trial certainly not required for cell therapy approval

.ProKidney has ceased one of a pair of stage 3 tests for its own tissue treatment for kidney conditi...

Vaxcyte surges on 'remarkable' 31-valent PCV succeed against Pfizer

.Vaxcyte introduced what professionals referred to as "spectacular" period 1/2 information for its o...

Recursion's human brain disease trial presents little documentation of effectiveness

.Recursion has actually discovered via a very early exam of its own tech-enabled method to medicatio...

Acepodia, Pfizer click on all together for chemistry-based tissue therapy

.Call it a scenario of really good chemistry: Acepodia, a biotech based upon Nobel Prize-winning sci...

Praxis epilepsy medication decreases seizures in stage 2 hearing

.Practice Preciseness Medicines has scored one more midphase win in epilepsy this year, along with i...

Three officers resign as Dyne articles blended information for DMD candidate

.After running away a scientific hold a number of years back, Dyne Therapy has revealed new period 1...

Arrowhead fires off stage 3 information in unusual metabolic condition before market encounter Ionis

.Arrowhead Pharmaceuticals has actually presented its hand ahead of a prospective showdown with Ioni...